Strata Skin科學 SSKN 深 滬
等待開盤 08-16 09:30:00 美东时间
1.82
+0.010
+0.55%
華盛通- 最 高1.84
- 今 開1.84
- 成交量 5460股
- 最 低 1.78
- 昨 收 1.81
- 總市值 759.16万
- 52周最高 3.79
- 市盈率 靜 --
- 換手率 0.13%
- 52周最低 1.78
- 委 比 -92.38%
- 總股本 417.12万
- 歷史最高 3480.00
- 量 比 0.62
- 振 幅 3.31%
- 歷史最低 1.78
- 每 手 1
- 風險率 1.05%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Strata Skin Sciences Q2 EPS $(0.60) Misses $(0.29) Estimate, Sales $7.70M Miss $8.56M Estimate
Strata Skin Sciences (NASDAQ:SSKN) reported quarterly losses of $(0.60) per share which missed the analyst consensus estimate of $(0.29) by 109.06 percent. This is a 1900 percent decrease over losses of $(0.03) per share
08-14 04:09
Earnings Scheduled For August 13, 2025
Companies Reporting Before The Bell • Evotec (NASDAQ:EVO) is projected to repor...
08-13 16:32
Preview: Strata Skin Sciences's Earnings
Strata Skin Sciences (NASDAQ:SSKN) is gearing up to announce its quarterly earn...
08-13 01:01
STRATA Skin Sciences Working With Centers For Medicare & Medicaid Services To Obtain Temporary Codes To Accelerate Access To Expanded Reimbursement For XTRAC Exicmer Laser Treatment
Peer-reviewed publications continue to validate Excimer Laser efficacy in vitiligo and treatmentSTRATA updates status of non-Excimer laser false advertising litigation
08-07 20:17
STRATA Skin Sciences Moves to Accelerate Medicare and Private Payer Coverage from Expanded CPT Code Expansion, Tripling Addressable Market to 30M+ Patients
STRATA Skin Sciences is working with CMS to secure temporary codes to accelerate reimbursement for its XTRAC® excimer laser treatment, expanding its use for inflammatory and autoimmune skin conditions. Recent peer-reviewed studies confirm the efficacy of 308-nm excimer laser therapy combined with JAK inhibitors for vitiligo, achieving high repigmentation rates. The company also updated its litigation against LaserOptek America, adding LaserOptek ...
08-07 12:15
STRATA Skin Sciences to Report Second Quarter 2025 Financial Results on August 13, 2025 and Provide Corporate Update
STRATA Skin Sciences, Inc. will release its Q2 2025 financial results on August 13, 2025, followed by a conference call at 4:30 p.m. ET to discuss the results and corporate updates. Callers in the U.S. can join at 1-866-524-3160, while international callers can dial 1-412-317-6760. A live webcast is available at a provided link. A telephonic replay will be available until August 20, 2025, and a webcast replay will be accessible until February 13,...
07-31 12:15
STRATA Skin Sciences Expands Reimbursement Eligibility For Excimer Laser Treatments To Include Multiple Inflammatory And Auto-Immune Skin Conditions Beyond Original Psoriasis Indication
STRATA Skin Sciences, Inc. ("STRATA" or the "Company") (NASDAQ:SSKN), a medical technology company dedicated to advancing dermatologic care through innovation, announces that the American Medical Association (AMA)
05-19 20:05
Strata Skin Sciences Q1 EPS $(0.58) Misses $(0.52) Estimate, Sales $6.81M Miss $7.28M Estimate
Strata Skin Sciences (NASDAQ:SSKN) reported quarterly losses of $(0.58) per share which missed the analyst consensus estimate of $(0.52) by 11.54 percent. This is a 39.58 percent increase over losses of $(0.96) per share
05-15 04:09
Earnings Scheduled For May 14, 2025
Companies Reporting Before The Bell • Cellebrite DI (NASDAQ:CLBT) is expected t...
05-14 16:32
Examining the Future: Co-Diagnostics's Earnings Outlook
Co-Diagnostics (NASDAQ:CODX) will release its quarterly earnings report on Thur...
05-08 05:03
